middle.news
Why Did Invion Delay Revealing Promising Skin Cancer Trial Results?
9:37am on Wednesday 11th of June, 2025 AEST
•
Healthcare
Read Story
Why Did Invion Delay Revealing Promising Skin Cancer Trial Results?
9:37am on Wednesday 11th of June, 2025 AEST
Key Points
No adverse events reported in initial six patients of Phase I/II trial
Treatment well tolerated with no pain, a key advantage over existing therapies
Observable lesion size reduction after a single treatment cycle
Disclosure delay due to data verification and compliance with ASX rules
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Invion (ASX:IVX)
OPEN ARTICLE